BAJAJ HEALTHCARE
|
BAJAJ HEALTHCARE Last 5 Year Financial Ratios History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 13.59 | -5.19 | 23.02 | 25.87 | 60.23 |
| CEPS(Rs) | 22.43 | 4.82 | 29.26 | 32.26 | 35.96 |
| DPS(Rs) | 1.00 | 1.00 | 1.00 | 1.50 | 2.75 |
| Book NAV/Share(Rs) | 142.04 | 100.86 | 133.23 | 119.02 | 187.26 |
| Tax Rate(%) | 6.69 | 14.09 | 18.74 | 20.40 | 30.05 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 15.22 | 16.12 | 17.26 | 17.45 | 20.76 |
| EBIT Margin(%) | 13.65 | 2.76 | 14.84 | 15.07 | 19.35 |
| Pre Tax Margin(%) | 8.48 | -3.52 | 12.11 | 13.19 | 18.09 |
| PAT Margin (%) | 7.91 | -3.03 | 9.84 | 10.50 | 12.65 |
| Cash Profit Margin (%) | 13.06 | 2.81 | 12.50 | 13.09 | 15.10 |
| Performance Ratios | |||||
| ROA(%) | 5.51 | -1.74 | 7.84 | 11.45 | 19.14 |
| ROE(%) | 11.81 | -4.44 | 18.25 | 24.33 | 38.09 |
| ROCE(%) | 11.40 | 1.88 | 14.02 | 20.00 | 35.91 |
| Asset Turnover(x) | 0.70 | 0.58 | 0.80 | 1.09 | 1.51 |
| Sales/Fixed Asset(x) | 1.26 | 1.00 | 1.39 | 1.86 | 2.20 |
| Working Capital/Sales(x) | 2.55 | 194.46 | 9.67 | 8.92 | 8.67 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.79 | 1.00 | 0.72 | 0.54 | 0.45 |
| Receivable days | 145.27 | 144.33 | 107.01 | 76.07 | 54.82 |
| Inventory Days | 102.90 | 136.01 | 104.01 | 68.82 | 37.89 |
| Payable days | 117.80 | 124.77 | 90.43 | 78.13 | 61.06 |
| Valuation Parameters | |||||
| PER(x) | 49.42 | - | 13.24 | 13.16 | 3.92 |
| PCE(x) | 29.94 | 60.73 | 10.42 | 10.55 | 6.56 |
| Price/Book(x) | 4.73 | 2.90 | 2.29 | 2.86 | 2.52 |
| Yield(%) | 0.15 | 0.34 | 0.33 | 0.44 | 0.58 |
| EV/Net Sales(x) | 4.31 | 2.40 | 1.91 | 1.76 | 1.24 |
| EV/Core EBITDA(x) | 22.94 | 13.37 | 10.93 | 9.94 | 5.70 |
| EV/EBIT(x) | 31.59 | 86.93 | 12.89 | 11.65 | 6.43 |
| EV/CE(x) | 3.40 | 1.86 | 1.58 | 1.66 | 1.56 |
| M Cap / Sales | 3.91 | 1.71 | 1.30 | 1.38 | 0.99 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 14.61 | -26.69 | -5.01 | 3.49 | 60.24 |
| Core EBITDA Growth(%) | 19.95 | -24.81 | -5.86 | -16.18 | 161.40 |
| EBIT Growth(%) | 466.58 | -86.36 | -6.45 | -19.42 | 197.86 |
| PAT Growth(%) | 399.64 | -122.55 | -11.00 | -14.11 | 229.32 |
| EPS Growth(%) | 361.84 | -122.55 | -11.00 | -57.05 | 229.32 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.50 | 1.19 | 1.13 | 0.78 | 0.70 |
| Current Ratio(x) | 1.78 | 1.01 | 1.15 | 1.24 | 1.41 |
| Quick Ratio(x) | 1.19 | 0.65 | 0.67 | 0.74 | 0.88 |
| Interest Cover(x) | 2.64 | 0.44 | 5.42 | 8.02 | 15.25 |
| Total Debt/Mcap(x) | 0.10 | 0.41 | 0.49 | 0.27 | 0.28 |
Compare Financial Ratios of peers of BAJAJ HEALTHCARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAJAJ HEALTHCARE | ₹1,175.1 Cr | 4% | 20.1% | -27.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,331.0 Cr | 1.2% | 8.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,466.0 Cr | -0.2% | 3% | -0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,952.0 Cr | 1.7% | 9.9% | 46.8% | Stock Analytics | |
| CIPLA | ₹116,229.0 Cr | -2.2% | 4.5% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,959.0 Cr | -9% | -2.1% | -1.8% | Stock Analytics | |
BAJAJ HEALTHCARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAJAJ HEALTHCARE | 4% |
20.1% |
-27.9% |
| SENSEX | -0.3% |
4.9% |
-7% |
You may also like the below Video Courses
